A61K 31/5386
Spiro-condensed or forming part of bridged ring systems
Official title: spiro-condensed or forming part of bridged ring systems
A61K31/5386 (Spiro-condensed or forming part of bridged ring systems) appears on 302 US grants and 721 published applications in this corpus.
Search patents in A61K- Granted patents
- 302
- Published applications
- 721
- Assignees
- 359
- Inventors
- 2,882
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 0 | 2 |
| 2004 | 1 | 3 |
| 2005 | 1 | 2 |
| 2006 | 1 | 3 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 3 |
| 2012 | 1 | 7 |
| 2013 | 3 | 12 |
| 2014 | 13 | 27 |
| 2015 | 22 | 35 |
| 2016 | 29 | 35 |
| 2017 | 28 | 31 |
| 2018 | 29 | 22 |
| 2019 | 14 | 25 |
| 2020 | 18 | 28 |
| 2021 | 21 | 39 |
| 2022 | 14 | 36 |
| 2023 | 19 | 51 |
| 2024 | 26 | 89 |
| 2025 | 35 | 154 |
| 2026 | 25 | 111 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Inhibitors and uses thereof22 Sep 2026US 12,740,991 B2Vividion Therapeutics, Inc.
- Quinoxaline derivatives and uses thereof22 Sep 2026US 12,741,976 B2Black Diamond Therapeutics, Inc.
- KRas inhibitors1 Sep 2026US 12,723,053 B2Eli Lilly and Company
- Compositions and methods for the treatment of motion sickness and emesis18 Aug 2026US 12,708,628 B2Repurposed Therapeutics, Inc.
- Aroyl substituted tricyclic compound, preparation method therefor and use thereof28 Jul 2026US 12,692,275 B2Genfleet Therapeutics (Shanghai) Inc.
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Oxazole trpml1 agonists and uses thereof1 Oct 2026US 2026/0297104 A1Libra Therapeutics, Inc.
- Ras inhibitors1 Oct 2026US 2026/0297112 A1Revolution Medicines, Inc.
- Bicyclic and heterocyclic amide compounds24 Sep 2026US 2026/0285857 A1Protego Biopharma, Inc.
Most cited
By later US patents
- Methods and compositions for applying pharmacologic agents to the ear44US 7,220,431 B2Regents of the University of Minnesota · 2007
- 1:1 adducts of sickle hemoglobin43US 9,248,199 B2Global Blood Therapeutics, Inc. · 2016
- Stable pharmaceutical solution formulations for pressurized metered dose inhalers28US 6,716,414 B2Chiesi Farmaceutici S.P. A. · 2004
- Hepatitis B antiviral agents26US 10,179,131 B2Enanta Pharmaceuticals, Inc. · 2019
- Compounds and compositions for the inhibition of NAMPT25US 9,169,209 B2Forma Tm, LLC · 2015